DYAI Stock Price, Chart, Stats & News

Dyadic International, Inc.
Save
29.37M
Market cap
–
Current P/E
15.82x
Forward P/E
DYAI chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 80.56% |
Operating margin | -231.23% |
Pretax margin | -238.31% |
Net margin | -238.31% |
Effective tax rate | – |
ROA | -74.05% |
ROE | -695.82% |
D/E | 5.78x |
Interest coverage ratio | -15.67x |
DYAI valuation
P/E | – |
P/S | 8.00x |
P/B | 17.97x |
P/CF | -3.88x |
P/FCF | -4.34x |
P/OCF | -3.88x |
PEG | -0.72x |
EV multiple | -3.11x |
About
Dyadic International, Inc. operates as a U. S.-based biotechnology platform company, specializing in the development, production, and commercialization of enzymes and other proteins. Its core activities are underpinned by a patented and proprietary C1 platform, alongside other advanced technologies.
Similar securities
Based on sector and market capitalization
Report issue











